High Adenoma Detection Rates in Fecal Immunochemical Test-Based Colorectal Cancer Screening: Interim Results of the National Bowel Cancer Screening Program in Qatar

被引：0

作者：

John, Anil K. ^{[1
]}

Varughese, Betsy ^{[1
]}

Abushaikha, Shaikha S. ^{[2
]}

Hamdan, Ahed M. ^{[3
]}

Pillai, Viswapriya ^{[1
]}

Ayash, Ahmad M. ^{[1
]}

Vincent, Paul K. ^{[1
]}

Sultan, Khaleel ^{[1
]}

Al Ejji, Khalid M. ^{[1
]}

Singh, Rajvir ^{[4
]}

Alabdulla, Samya ^{[5
]}

Abdulmalik, Mariam ^{[5
]}

Al Kaabi, Saad ^{[1
]}

机构：

[1] Hamad Med Corp, Gastroenterol & Hepatol, Doha, Qatar

[2] Primary Hlth Care Corp, Community Med, Doha, Qatar

[3] Primary Hlth Care Corp, Preventat Hlth Screening Programs, Doha, Qatar

[4] Hamad Med Corp, Heart Hosp, Cardiol Res, Doha, Qatar

[5] Primary Hlth Care Corp, Family Med, Doha, Qatar

来源：

CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 12期

关键词：

crc; adenoma detection; bowel cancer screening; colorectal cancer; fecal immunochemical test; OCCULT BLOOD-TEST; QUALITY INDICATORS; COLONOSCOPY; PREVENTION; GUIDELINES; MORTALITY; WORLDWIDE; CRITERIA; SOCIETY;

D O I：

10.7759/cureus.32274

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction: Colorectal cancer is one of the most common cancers globally. Recent reductions in mortality rates have been primarily attributed to screening programs. The State of Qatar established a national bowel cancer screening program in 2016. Methodology: Fecal immunochemical testing (FIT) was used for average-risk individuals aged 50 to 74 years. Fecal immunochemical testing -positive participants were referred for total colonoscopy to detect polyps and cancers. Results: Among 32,751 FIT invitees, 11,130 took the test, and 758 (6%) of those were FIT positive. Of these, 375 (56.13%) participants underwent a colonoscopy, and polyps were detected in 198 (52.8%) and cancers in 19 (5.1%) participants. The adenoma detection rate exceeded 40%. Discussion and conclusion: The high yield of polyps and cancers in the screening program justifies an active, resource-intensive, and organized bowel cancer screening effort. The high adenoma detection rate in a FIT-based program warrants recalibration of target adenoma detection rates in screening programs.

引用

页数：6

共 50 条

[21] Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
van de Schootbrugge-vandermeer, Hilliene J.
Kooyker, Arthur I.
Wisse, Pieter H. A.
Nagtegaal, Iris D.
Geuzinge, Hiltje A.
Toes-Zoutendijk, Esther
de Jonge, Lucie
Breekveldt, Emilie C. H.
van Vuuren, Anneke J.
van Kemenade, Folkert J.
Ramakers, Christian R. B.
Dekker, Evelien
Lansdorp-Vogelaar, Iris
Spaander, Manon C. W.
van Leerdam, Monique E.
ENDOSCOPY, 2023, 55 (12) : 1061 - 1069
[22] Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
Mikkelsen, Ellen M.
Thomsen, Mette Kielsholm
Tybjerg, Julie
Friis-Hansen, Lennart
Andersen, Berit
Jorgensen, Jens Christian Riis
Baatrup, Gunnar
Njor, Sisse H.
Mehnert, Frank
Rasmussen, Morten
CLINICAL EPIDEMIOLOGY, 2018, 10 : 1649 - 1655
[23] Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
Manon van der Vlugt
Esmée J Grobbee
Patrick MM Bossuyt
Evelien Bongers
Wolfert Spijker
Ernst J Kuipers
Iris Lansdorp-Vogelaar
Marie-Louise Essink-Bot
Manon C W Spaander
Evelien Dekker
British Journal of Cancer, 2017, 116 : 44 - 49
[24] Similar fecal immunochemical test results in screening and referral colorectal cancer
van Turenhout, Sietze T.
van Rossum, Leo G. M.
Oort, Frank A.
Laheij, Robert J. F.
van Rijn, Anne F.
Droste, Jochim S. Terhaar Sive
Fockens, Paul
van der Hulst, Rene W. M.
Bouman, Anneke A.
Jansen, Jan B. M. J.
Meijer, Gerrit A.
Dekker, Evelien
Mulder, Chris J. J.
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (38) : 5397 - 5403
[25] Similar fecal immunochemical test results in screening and referral colorectal cancer
Sietze T van Turenhout
Leo GM van Rossum
Frank A Oort
Robert JF Laheij
Anne F van Rijn
Jochim S Terhaar sive Droste
Paul Fockens
René WM van der Hulst
Anneke A Bouman
Jan BMJ Jansen
Gerrit A Meijer
Evelien Dekker
Chris JJ Mulder
World Journal of Gastroenterology, 2012, (38) : 5397 - 5403
[26] Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
van der Vlugt, Manon
Grobbee, Esmee J.
Bossuyt, Patrick M. M.
Bongers, Evelien
Spijker, Wolfert
Kuipers, Ernst J.
Lansdorp-Vogelaar, Iris
Essink-Bot, Marie-Louise
Spaander, Manon C. W.
Dekker, Evelien
BRITISH JOURNAL OF CANCER, 2017, 116 (01) : 44 - 49
[27] Equal Advanced Neoplasia Detection Rates in First and Second Round of an Fecal Immunochemical Test Based Colorectal Cancer Screening Program
Denters, Maaike
Deutekom, Marije
Bossuyt, Patrick M.
Fockens, Paul
Dekker, Evelien
GASTROENTEROLOGY, 2010, 138 (05) : S186 - S186
[28] Evidence of elevated colorectal cancer and adenoma rates for regional National Bowel Cancer Screening Program participants
Versace, Vincent L.
Forsyth, Anton D.
Vaughan, Rose
Morrice, Margie G.
Morphett, Barry J.
AUSTRALIAN JOURNAL OF RURAL HEALTH, 2018, 26 (01) : 63 - 64
[29] SEVERE COLONOSCOPY-RELATED COMPLICATION IN A FECAL IMMUNOCHEMICAL TEST-BASED SCREENING PROGRAM: ANALYSIS OF NATIONWIDE COLORECTAL CANCER SCREENING AND ADMINISTRATIVE DATABASE
Chiu, Han-Mo
Hsu, Wen-Feng
Lee, Yi-Chia
Chang, Li-Chun
Wu, Ming-Shiang
GASTROENTEROLOGY, 2018, 154 (06) : S575 - S575
[30] Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program
O'Reilly, Susanne M.
MacNally, Sara
O'Donoghue, Diarmuid
Mooney, Therese
Fitzpatrick, Patricia
Mulcahy, Hugh E.
Cullen, Garret
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (01)

← 1 2 3 4 5 →